Pneumothorax in Infants with Suspected Pertussis
Clinical Presentation of Pneumothorax
Pneumothorax is a recognized complication of severe pertussis in infants, resulting from the intense pressure generated during paroxysmal coughing episodes. 1
Key Symptoms to Recognize:
- Sudden deterioration in respiratory status during or after severe coughing paroxysms 1
- Unilateral decreased chest expansion on the affected side 2
- Dullness to percussion (though this may be less reliable in small infants) 2
- Reduced or absent breath sounds on the affected side 2
- Cyanosis due to ventilation-perfusion mismatch, which may worsen acutely 2
- Increased work of breathing with tachypnea and retractions 1
- Oxygen saturation below 92% indicating severe disease 2
Context of Pertussis Presentation:
Infants with pertussis typically present with atypical disease features before pneumothorax develops 1:
- Apneic spells as the initial presentation, often with minimal cough 1
- Paroxysmal coughing that increases in frequency and severity over 2-6 weeks 1
- Post-tussive vomiting following coughing episodes 1
- Worsening symptoms at night when paroxysms are most frequent 1
Diagnostic Approach
Immediate Evaluation:
- Chest radiograph (anteroposterior view) to identify air in the pleural space 2
- Transillumination at the bedside for rapid assessment in unstable infants 3
- Lung ultrasound as an alternative rapid diagnostic tool 3
- Oxygen saturation monitoring with levels below 92% indicating severe disease requiring urgent intervention 2
Ultrasound must be used to confirm the presence of pleural air and guide any intervention. 2
Pertussis Confirmation:
- Nasopharyngeal culture and PCR testing to confirm pertussis diagnosis 1
- Blood culture to rule out secondary bacterial pneumonia 2
Treatment Algorithm
Immediate Management of Pneumothorax:
- Observation alone for small, asymptomatic pneumothoraces in stable infants 3
- Needle thoracocentesis for symptomatic pneumothorax causing respiratory compromise 3
- Chest tube placement (pigtail or straight) for large or tension pneumothorax 3
Pertussis-Specific Treatment:
Azithromycin is the preferred first-line antibiotic for infants with pertussis, regardless of disease stage. 1, 4
- Macrolide antibiotics reduce duration and severity of symptoms when given early 1
- Supportive care is the mainstay of management, including monitoring for apneic episodes 1
- Hospital admission is mandatory for infants under 6 weeks with pertussis, typically requiring 2-6 weeks of hospitalization depending on complications 1
Monitoring for Additional Complications:
Infants with pertussis and pneumothorax are at high risk for multiple complications 5, 6:
- Pulmonary hypertension requiring aggressive management 5, 6
- Seizures from hypoxia or encephalopathy 1, 5
- Secondary bacterial pneumonia occurring in approximately 13% of cases 1
- Feeding difficulties and weight loss requiring nutritional support 1
Critical Risk Factors
Age less than 6 months, particularly under 2 months, carries the highest risk for severe disease and death with a case-fatality ratio of 1.8%. 1
Additional high-risk features include 1:
- Unvaccinated or incompletely vaccinated status
- Prematurity (gestational age <37 weeks)
- Hispanic ethnicity (observed in mortality studies)
Infection Control and Prophylaxis
Isolation Requirements:
- Respiratory droplet precautions until 5 days of appropriate antibiotic treatment are completed 2, 4
- Surgical mask should be worn by healthcare workers within 3 feet of the patient 2
Household Contact Management:
All household and close contacts must receive macrolide antibiotic prophylaxis for 14 days, regardless of age and vaccination status. 7
- Erythromycin for 14 days (40-50 mg/kg/day for children) 7
- Azithromycin for 5 days (10 mg/kg day 1, then 5 mg/kg/day for 4 days) 7
- Clarithromycin for 10-14 days (15-20 mg/kg/day in two divided doses) 7
Common Pitfalls to Avoid
- Failing to consider pertussis in young infants presenting with apnea and minimal cough, delaying diagnosis until pneumothorax develops 1, 8
- Underestimating severity based on initial presentation, as infants can deteriorate rapidly 5
- Delaying chest imaging when respiratory status changes during paroxysmal coughing 2
- Not providing prophylaxis to all household contacts, allowing continued transmission 7
- Assuming vaccination provides complete protection, as maternal antibodies wane and infants are vulnerable before completing their primary series 1